19 results
DRS
MAIA
MAIA Biotechnology Inc
1 Jun 23
Draft registration statement
12:00am
in the event of unsafe use of cemiplimab, material breach, regulatory action or corruption.
In addition, our management believes that strong
424B4
MAIA
MAIA Biotechnology Inc
25 Apr 23
Prospectus supplement with pricing info
7:45pm
be terminated in the event of unsafe use of cemiplimab, material breach, regulatory action or corruption.
In addition, our management believes that strong
DRS
ggx5bshf im9gfih8qen
23 Dec 22
Draft registration statement
12:00am
424B4
rrctz2oxd560
29 Jul 22
Prospectus supplement with pricing info
8:31am
S-1
EX-10.1
2owxw pew
8 Apr 22
IPO registration
8:21pm
S-1
v4k3brtnvqs4396s
8 Apr 22
IPO registration
8:21pm
DRS/A
bqwqy
22 Dec 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next